[1]
|
Bymaster, F.P., Hemrick-Luecke, S.K., Perry, K.W. and Fuller, R.W. (1996) Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic, receptors in vivo in rats. Psychopharmacology, 124, 87-94. doi:10.1007/BF02245608
|
[2]
|
Bymaster, F.P., Nelson, D.L., DeLapp, N.W., Falcone, J.F., Eckols, K., Truex, L.L., Foreman, M.M., Lucaites, V.L. and Calligaro, D.O. (1999) Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro. Schizophrenia Research, 37, 107-122.
doi:10.1016/S0920-9964(98)00146-7
|
[3]
|
Razaq, M. and Samma, M. (2004) A case of risperdone-induced hypothermia. American Journal of Therapeutics, 11, 229-230. doi:10.1097/00045391-200405000-00012
|
[4]
|
Danzl, D. (2002) Hypothermia. Seminars in Respiratory and Critical Care Medicine, 23, 57-68.
doi:10.1055/s-2002-20589
|
[5]
|
Blass, D.M. and Chuen, M. (2004) Olanzapine-associated hypothermia. Psychosomatics, 45, 135-139.
doi:10.1176/appi.psy.45.2.135
|
[6]
|
H?gg, S., Mj?rndal, T. and Lindqvist, L. (2001) Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. Journal of Clinical Psychopharmacology, 21, 113-115.
doi:10.1097/00004714-200102000-00023
|
[7]
|
Kreuzer, P., Landgrebe, M., Hajak, G., Burger, S.J. and Langguth, B. (2011) A case of severe hypothermia following single-dose administration of olanzapine: A case report. Journal of Clinical Psychopharmacology, February, 22.
|
[8]
|
Kreuzer, P., Landgrebe, M., Wittmann, M., Hajak, G., Schencklmann, M., Poeppl, T.B. and Langguth, B. (2011) Hypothermia under olanzepine treatment: Clinical case series and review of current literature. Der Nervenarzt, 83, 630-637. doi:10.1007/s00115-011-3310-y
|
[9]
|
Rasnayake, L.R., Wimalarathne, H., Jayapala, R.K., Gamage, C.D., Dassanayake, D.L., Ratnayake, S.L., Colombage, A., Nandadeva, D. and Nelumdeniya, A.N. (2011) An usual case of hypothermia associated with therapeutic doses of olanzapine: A case report. Journal of Medical Case Reports, 18, 189.
|
[10]
|
Norris, M.L., Spettigue, W., Buchhol, A., Henderson, K.A., Gomez, R., Maras, D., Gaboury, I. and Ni, A. (2011) Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa. Journal of Child and Adolescent Psychopharmacology, 21, 213-220.
doi:10.1089/cap.2010.0131
|
[11]
|
Hein, I.M. and Huyser, C. (2010) Olanzepine in de behandeling van adolescenten met anorexia nervosa. Tijdschrift voor Psychiatrie, 52, 417-421.
|
[12]
|
Phan, T.G., Yu, R.Y. and Hersch, M. (1998) Hypothermia induced by risperdone and olanzapine in a patient with Prader-Willi syndrome. Medical Journal of Australia, 169, 230-231.
|
[13]
|
Parris, C., Mack, J.M., Cochiolo, J.A., Steinmann, A.F. and Tietjen, J. (2001) Hypothermia in 2 patients treated with atypical antipsychotic medication. Journal of Clinical Psychopharmacology, 62, 61-63.
doi:10.4088/JCP.v62n0112g
|
[14]
|
Fukunishi, I., Sato, Y., Kino, K., Shirai, T. and Kitaoka, T. (2003) Hypothermia in a hemodialysis patient treated with olanzepine monotherapy. Journal of Clinical Psychopharmacology, 23, 314.
doi:10.1097/00004714-200306000-00013
|
[15]
|
Lee, T.W., Tsai, S.J. and Hwang, J.P. (2003) Severe cardiovascular side effects of olanzapine in an eldery patient: Case report. The International Journal of Psychiatry in Medicine, 33, 399-401.
doi:10.2190/U99G-XDML-0GRG-BYE0
|
[16]
|
Hung, C.F., Huang, T.Y. and Lin, P.Y. (2009) Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder. General Hospital Psychiatry, 31, 376-378.
doi:10.1016/j.genhosppsych.2008.09.009
|
[17]
|
Mu?oz, M.T. and Argente, J. (2002) Anorexia nervosa in female adolescents: Endocrine and bone mineral density disturbances. European Journal of Endocrinology, 147, 275-286. doi:10.1530/eje.0.1470275
|
[18]
|
Oerther, S. and Ahlenius, S. (2000) Atypical antipsychotics and dopamine D(1) receptor agonism: An in vivo experimental study using core temperature measurements in the rat. Journal of Pharmacology and Experimental Therapeutics, 29, 731-736.
|